Free CME and CE Credits – General Information
Target Audience
The NIAAA Core Resource on Alcohol provides CME/CE credit for physicians, physician assistants, nurses, pharmacists, psychologists, and social workers, as well as other healthcare professionals whose licensing boards accept APA or AMA credits. ABIM-certified physicians can also earn MOC credits. Others may earn a certificate of completion.
Joint Accreditation Statement
In support of improving patient care, CME/CE activities offered have been planned and implemented by the Postgraduate Institute for Medicine and NIAAA. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
There are two credit paths—please choose the one that aligns with your profession. Learners who complete all 14 articles can receive a maximum of 10.75 credits.
These professionals can earn 0.75 to 1.0 credits for reading any single article:
- Physicians (and others who can earn AMA credit)
- Physician Assistants
- Nurses
- Pharmacists
These professionals can earn 1.5 to 1.75 credits for reading a pair of articles as indicated in the table below:
- Licensed Psychologists (and others who can earn APA credit)
- Social Workers
The tables below indicate the credit amount that can be earned for each individual article or each pair of articles. Articles (or pairs) can be completed in any order and free CME/CE credit can be earned for as many or as few as desired. CME University keeps a log of articles completed for credit. To view the course history, login to CME University, then under the “User Menu,” click on “My History” to see the date of participation, course title, post-test results, and credits earned.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 10.75 AMA PRA Category 1 Credit(s)™.
An American Board of Addiction Medicine (ABAM) Recognized Activity: This course is a recognized activity for ABAM Diplomates enrolled in the Transitional Continuous Certification Program (TraCC). This course has been recognized by ABAM. Physicians enrolled in ABAM TraCC can apply a maximum of 10.75 AMA PRA Category 1 Credits™ for completing The Healthcare Professional's Core Resource on Alcohol.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.75 AAPA Category 1 CME credits.
Continuing Nursing Education
Continuing Nursing Education The maximum number of hours awarded through the American Nurses Credentialing Center (ANCC) for this Continuing Nursing Education activity is 10.75 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 10.75 contact hour(s) (1.075 CEUs) of the Accreditation Council for Pharmacy Education (ACPE).
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. This program offers 10.75 continuing education credits for psychologists.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. The Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course can receive up to 10.75 clinical continuing education credits.
American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Program
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Table 1: For Physicians (and others who can earn AMA credit), Physician Assistants, Nurses, and Pharmacists.
Learners seeking AMA, AAPA, ANCC, or ACPE credit who complete all 14 Core Topic Articles can receive a maximum of 10.75 credits. The table below indicates the credit amount that can be claimed for each individual article.
| Core Topic | Article Title | Credit Total | Activity UAN |
|---|---|---|---|
| 1 | The Basics: Defining How Much Alcohol is Too Much | 0.75 | JA4008162-9999-24-195-H01-P Type of Activity: Knowledge |
| 2 | Risk Factors: Varied Vulnerability to Alcohol-Related Harm | 0.75 | JA4008162-9999-24-196-H01-P Type of Activity: Knowledge |
| 3 | Neuroscience: The Brain in Addiction and Recovery | 0.75 | JA4008162-9999-24-197-H01-P Type of Activity: Knowledge |
| 4 | Stigma: Overcoming a Pervasive Barrier to Optimal Care | 0.75 | JA4008162-9999-24-199-H01-P Type of Activity: Knowledge |
| 5 | Medical Complications: Common Alcohol-Related Concerns | 1.00 | JA4008162-9999-24-198-H01-P Type of Activity: Knowledge |
| 6 | Alcohol-Medication Interactions: Potentially Dangerous Mixes | 0.75 | JA4008162-9999-24-200-H01-P Type of Activity: Knowledge |
| 7 | Mental Health Issues: Alcohol Use Disorder and Common Co-occurring Conditions | 0.75 | JA4008162-9999-24-201-H01-P Type of Activity: Knowledge |
| 8 | Alcohol Use Disorder: From Risk to Diagnosis to Recovery | 0.75 | JA4008162-9999-24-202-H01-P Type of Activity: Knowledge |
| 9 | Screen and Assess: Use Quick, Effective Methods | 0.75 | JA4008162-9999-24-203-H01-P Type of Activity: Knowledge |
| 10 | Conduct a Brief Intervention: Build Motivation and a Plan for Change | 0.75 | JA4008162-9999-24-204-H01-P Type of Activity: Knowledge |
| 11 | Recommend Evidence-Based Treatment: Know the Options | 0.75 | JA4008162-9999-24-205-H01-P Type of Activity: Knowledge |
| 12 | Make Referrals: Connect Patients to Alcohol Treatment That Meets Their Needs | 0.75 | JA4008162-9999-24-206-H01-P Type of Activity: Knowledge |
| 13 | Support Recovery: It’s a Marathon, Not a Sprint | 0.75 | JA4008162-9999-24-207-H01-P Type of Activity: Knowledge |
| 14 | Promote Practice Change: Take Manageable Steps Toward Better Care | 0.75 | JA4008162-9999-24-208-H01-P Type of Activity: Knowledge |
Table 2: For Psychologists (and others who can earn APA credit) and Social Workers.
Learners seeking APA or ASWB credit must complete the following pairs of articles together in order to receive credit. Learners who complete all 7 pairs (14 articles) can receive a maximum of 10.75 credits.
| Core Topics | Article Title | Credit Amount |
|---|---|---|
| 1 2 |
The Basics: Defining How Much Alcohol is Too Much Who’s at Risk for What? Varied Vulnerability to Alcohol-Related Harm |
1.5 |
| 3 4 |
Neuroscience: The Brain in Addiction and Recovery Stigma: Overcoming a Pervasive Barrier to Optimal Care |
1.5 |
| 5 6 |
Medical Complications: Common Alcohol-Related Concerns Alcohol-Medication Interactions: Potentially Dangerous Mixes |
1.75 |
| 7 8 |
Mental Health Issues: Alcohol Use Disorder and Commonly Co-occurring Conditions Alcohol Use Disorder: From Risk to Diagnosis to Recovery |
1.5 |
| 9 10 |
Screen and Assess: Use Quick, Effective Methods Conduct a Brief Intervention: Build Motivation and a Plan for Change |
1.5 |
| 11 13 |
Recommend Evidence-Based Treatment: Know the Options Support Recovery: It’s a Marathon, Not a Sprint |
1.5 |
| 12 14 |
Make Referrals: Connect Patients to Alcohol Treatment That Meets Their Needs Promote Practice Change: Take Manageable Steps Toward Better Care |
1.5 |
Disclosure of Financial Relationships
The Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The following financial relationships have been reported to Postgraduate Institute for Medicine (PIM). PIM has evaluated, identified, and mitigated any potential conflict of interest. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the education.
Dr. Michael Charness reports he is a stock shareholder of Pfizer.
Dr. H. Westley Clark discloses Speakers Bureau/Honorarium for non-CME from Indivior.
Dr. Zhigang (Peter) Gao discloses that he is a stock shareholder of Cassava, Geron and Moderna.
Dr. Deborah Hasin reports contracted research with Syneos Health.
Dr. John Krystal reports that he receives consulting fees from Aptinyx, Inc., Atai Life Sciences, Biogen Idec MA, Bionomics, Limited (Australia), Boehringer Ingelheim International, Cadent Therapeutics, Inc., Clexio Bioscience, Ltd., COMPASS Pathways, Limited, United Kingdom, Concert Pharmaceuticals Inc., Epiodyne Inc., EpiVario Inc., Greenwich Biosciences Inc., Heptares Therapeutics, Limited (UK), Janssen Research & Development, Jazz Pharmaceuticals, Inc., Otsuka America Pharmaceutical, Inc., Perception Neuroscience Holdings, Inc., Spring Care, Inc., Sunovion Pharmaceuticals, Inc., Takeda Industries and Taisho Pharmaceutical Co., Ltd. He is on the Board of Directors with Freedom Biosciences, Inc. Dr. Krystal is on the Scientific Advisory Board with Biohaven Pharmaceuticals, BioXcel Therapeutics, Inc. (Clinical Advisory Board), Cadent Therapeutics, Inc. (Clinical Advisory Board), Cerevel Therapeutics, LLC, Delix Therapeutics, Inc., EpiVario, Inc., Eisai, Inc., Jazz Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, PsychoGenics, Inc., Neumora Therapeutics, Inc., Tempero Bio, Inc., and Terran Biosciences, Inc. He reports he is a stock shareholder of Biohaven Pharmaceuticals, Sage Pharmaceuticals, and Spring Care Inc. Dr. Krystal discloses that he receives patent royalties from Biohaven Pharmaceuticals and Janssen Pharmaceuticals. He reports receiving research support from AstraZeneca Pharmaceuticals, Novartis, and Cerevel.
Dr. Evette Ludman discloses she is a stock share holder of Merck.
Dr. Barbara Mason reports consulting fees from Imbrium Theraputics. She is a stock share holder with Awakn Life Sciences Corporation.
Dr. Mack Mitchell discloses that he receives consulting fees from Mallinckrodt and Prodigy. He is a stock shareholder of Abbvie, Amygdala, Sunhydrogen and Moderna.
Dr. Olivier George discloses that he receives patent royalties from Cessation Therapeutics.
Dr. Patricia Powell reports she is a stock shareholder of Pfizer.
Dr. Arun Sanyal discloses that he receives patent royalties from Sanyal Bio. He receives consulting fees from Akero, Alnylam, Amgen, AstraZeneca, Blade, Boehringer Ingelheim, Bristol Myers Squibb, Enyo, Genentech, Gilead, Glympse, Histoindex, Intercept, Lilly, Madrigal, Mallinckrodt, Merck, Novo Nordisk, Path AI, Pfizer, Pliant, Poxel, Regeneron, Rivus, Salix, Siemens, Surrozen, Tern, Thera Technologies, Valeant, and Zydus. He is a stock shareholder of Durect, Exhalenz, Genfit, Hemoshear, and Indalo and Sanyal Bio.
Dr. Schatzberg discloses that he receives consulting fees from Alto, ANeuroTech, Axsome, Boehringer-Ingelheim, Bracket, Cambridge Health Partners, Compass, Delpor, EMA, Jazz, McKinsey, Myriad Genetics, NeuraWell, Otsuka, Owl Insights, Sage, Schwabe, Signant, Skyland Trail, and Tris. He is stock shareholder of Alto, Corcept (co-founder), Delpor, Epiodyne, Intersect ENT, Madrigal, Nesos, NeuraWell, Owl Insights, Seattle Genetics, Titan, and Xhale.
Dr. Vijay Shah reports that he receives consulting fees from Ambys Medicines, Durect Corporation, HepaRegeniX, Novartis Pharma AG, Akaza Bioscience Ltd., AgomAb Therapeutics, Generon Shangai, Intercept Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, and Surrozen.
Disclosure of Unlabeled Use
All CME/CE activities may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activities are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in the CME/CE activities are not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.